4QXT
Crystal Structure of anti-MSP2 Fv fragment (mAb6D8)in complex with FC27-MSP2 14-30
4QXT の概要
| エントリーDOI | 10.2210/pdb4qxt/pdb |
| 関連するPDBエントリー | 4QY8 4QYO |
| 分子名称 | Fv fragment(mAb6D8) heavy chain, Fv fragment(mAb6D8) light chain, Merozoite surface antigen 2, ... (4 entities in total) |
| 機能のキーワード | immunoglobulin fold, immune system, n-terminal msp2, unstructured antigen |
| 由来する生物種 | Mus musculus 詳細 |
| 細胞内の位置 | Cell membrane; Lipid-anchor, GPI-anchor: Q03643 |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 26390.11 |
| 構造登録者 | Morales, R.A.V.,MacRaild, C.A.,Seow, J.,Bankala, K.,Drinkwater, N.,McGowan, S.,Rouet, R.,Christ, D.,Anders, R.F.,Norton, R.S. (登録日: 2014-07-22, 公開日: 2015-06-03, 最終更新日: 2024-10-30) |
| 主引用文献 | Morales, R.A.,MacRaild, C.A.,Seow, J.,Krishnarjuna, B.,Drinkwater, N.,Rouet, R.,Anders, R.F.,Christ, D.,McGowan, S.,Norton, R.S. Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate. Sci Rep, 5:10103-10103, 2015 Cited by PubMed Abstract: Merozoite surface protein 2 (MSP2) is an intrinsically disordered, membrane-anchored antigen of the malaria parasite Plasmodium falciparum. MSP2 can elicit a protective, albeit strain-specific, antibody response in humans. Antibodies are generated to the conserved N- and C-terminal regions but many of these react poorly with the native antigen on the parasite surface. Here we demonstrate that recognition of a conserved N-terminal epitope by mAb 6D8 is incompatible with the membrane-bound conformation of that region, suggesting a mechanism by which native MSP2 escapes antibody recognition. Furthermore, crystal structures and NMR spectroscopy identify transient, strain-specific interactions between the 6D8 antibody and regions of MSP2 beyond the conserved epitope. These interactions account for the differential affinity of 6D8 for the two allelic families of MSP2, even though 6D8 binds to a fully conserved epitope. These results highlight unappreciated mechanisms that may modulate the specificity and efficacy of immune responses towards disordered antigens. PubMed: 25965408DOI: 10.1038/srep10103 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.58 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






